Akero Therapeutics, Inc.

AKRO

Log in to follow and get free email alerts when insiders file.

Sector

Pharmaceutical Preparations

Industry

Drugs

Website

Recent Filings - SEC Insider Transactions (Form 3,4,5)

Date
  • today
  • yesterday
  • week
Price per share
Shares

Transaction Codes

File Date
 
Date
 
Company
 
Filer
 
Security
 
Shares
 
Price
 
$ Total
 
% Change
 
10%
 
Dir.
 
Off.
 
Code
 
View
 
SEC
 
SIC
 
SIC Group
 
SIC Division
 

      Rows per page:

      100

      0-0 of 0

    Buy / Sell (dollars)

    1 Month

    4.6%95.4%

    $59,998.59

    avg. $59,998.59

    $1.23M

    avg. $1.23M

    Buy/Sell Ratio

    0.049


    Transactions

    6

    Filers

    4

    3 Month

    3.9%96.1%

    $142,275.00

    avg. $142,275.00

    $3.51M

    avg. $1.17M

    Buy/Sell Ratio

    0.041


    Transactions

    15

    Filers

    12

    12 Month

    11.9%88.1%

    $276,733.35

    avg. $276,733.35

    $2.05M

    avg. $171,078.78

    Buy/Sell Ratio

    0.135


    Transactions

    38

    Filers

    35

    24 Month

    40.1%59.9%

    $30.32M

    avg. $30.32M

    $45.31M

    avg. $1.89M

    Buy/Sell Ratio

    0.669


    Transactions

    130

    Filers

    83

    Filers

    CIK
    Name
    Title
    Last Transaction
    First Transaction
    Director
    Officer
    10% Own.
    Other
    1779308Yale CatrionaChief Development Officer2021-09-172019-12-13
    1779805Young JonathanChief Operating Officer2021-09-032019-12-13
    1778307Cheng AndrewChief Executive Officer2021-09-032019-12-13
    1778739White William RichardChief Financial Officer2021-09-032019-12-13
    1871695Judy Chou2021-07-142021-07-14
    1593440Apple Tree Partners IV, L.P.2021-06-302020-07-14
    1777517Graham G. Walmsley2021-06-032019-11-12
    1814673Heyman Tomas J.2021-06-032021-06-03
    1858214Xu Yuan2021-06-032021-04-26
    1415537Iwicki Mark T2021-06-032020-06-02
    1422304Henderson Jane2021-06-032020-06-02
    1591747Bitterman Kevin2021-06-032019-11-12
    1404955Harrison Seth Loring2021-06-032019-11-12
    1779479Rolph TimothyChief Scientific Officer2020-12-092019-12-13
    1687880Versant Venture Capital VI, L.P.2020-07-102019-12-19